|
1
|
Mertens J, Weyler J, Dirinck E, Vonghia L,
Kwanten WJ, Mortelmans L, Peleman C, Chotkoe S, Spinhoven M,
Vanhevel F, et al: Prevalence, risk factors and diagnostic accuracy
of non-invasive tests for NAFLD in people with type 1 diabetes.
JHEP Rep. 5(100753)2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wong VWS, Ekstedt M, Wong GL and Hagström
H: Changing epidemiology, global trends and implications for
outcomes of NAFLD. J Hepatol. 79:842–852. 2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Patel AH, Peddu D, Amin S, Elsaid MI,
Minacapelli CD, Chandler TM, Catalano C and Rustgi VK: Nonalcoholic
fatty liver disease in lean/nonobese and obese individuals: A
comprehensive review on prevalence, pathogenesis, clinical
outcomes, and treatment. J Clin Transl Hepatol. 11:502–515.
2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Adams LA, Anstee QM, Tilg H and Targher G:
Non-alcoholic fatty liver disease and its relationship with
cardiovascular disease and other extrahepatic diseases. Gut.
66:1138–1153. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Li AA, Ahmed A and Kim D: Extrahepatic
manifestations of nonalcoholic fatty liver disease. Gut Liver.
14:168–178. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Day CP and James OF: Steatohepatitis: A
tale of two ‘hits’? Gastroenterology. 114:842–845. 1998.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tilg H and Moschen AR: Evolution of
inflammation in nonalcoholic fatty liver disease: The multiple
parallel hits hypothesis. Hepatology. 52:1836–1846. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tomeno W, Yoneda M, Imajo K, Ogawa Y,
Kessoku T, Saito S, Eguchi Y and Nakajima A: Emerging drugs for
non-alcoholic steatohepatitis. Expert Opin Emerg Drugs. 18:279–290.
2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pessayre D and Fromenty B: NASH: A
mitochondrial disease. J Hepatol. 42:928–940. 2005.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lian B, Cai L, Zhang Z, Lin F, Li Z, Zhang
X and Jiang F: The anti-inflammatory effect of Pien Tze Huang in
non-alcoholic fatty liver disease. Biomed Pharmacother.
151(113076)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Jurisic V, Terzic T, Colic S and Jurisic
M: The concentration of TNF-alpha correlate with number of
inflammatory cells and degree of vascularization in radicular
cysts. Oral Dis. 14:600–607. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sanyal AJ, Friedman SL, McCullough AJ and
Dimick-Santos L: American Association for the Study of Liver
Diseases; United States Food and Drug Administration. Challenges
and opportunities in drug and biomarker development for
nonalcoholic steatohepatitis: Findings and recommendations from an
American association for the study of liver diseases-U.S. food and
drug administration joint workshop. Hepatology. 61:1392–1405.
2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
U.S. Food and Drug Administration (FDA):
FDA Approves First Treatment for Patients with Liver Scarring Due
to Fatty Liver Disease. FDA, Silver Spring, MD, 2024. https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease.
|
|
14
|
Takahashi Y, Sugimoto K, Inui H and
Fukusato T: Current pharmacological therapies for nonalcoholic
fatty liver disease/nonalcoholic steatohepatitis. World J
Gastroenterol. 21:3777–3785. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Flora K, Hahn M, Rosen H and Benner K:
Milk thistle (Silybum marianum) for the therapy of liver
disease. Am J Gastroenterol. 93:139–143. 1998.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kalopitas G, Antza C, Doundoulakis I,
Siargkas A, Kouroumalis E, Germanidis G, Samara M and Chourdakis M:
Impact of Silymarin in individuals with nonalcoholic fatty liver
disease: A systematic review and meta-analysis. Nutrition.
83(111092)2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ye Y, Liu X, Wu N, Han Y, Wang J, Yu Y and
Chen Q: Efficacy and safety of berberine alone for several
metabolic disorders: A systematic review and meta-analysis of
randomized clinical trials. Front Pharmacol.
12(653887)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Banach M, Patti AM, Giglio RV, Cicero AFG,
Atanasov AG, Bajraktari G, Bruckert E, Descamps O, Djuric DM, Ezhov
M, et al: The role of nutraceuticals in statin intolerant patients.
J Am Coll Cardiol. 72:96–118. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sukhija R, Prayaga S, Marashdeh M, Bursac
Z, Kakar P, Bansal D, Sachdeva R, Kesan SH and Mehta JL: Effect of
statins on fasting plasma glucose in diabetic and nondiabetic
patients. J Investing Med. 57:495–499. 2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Liu QZ, Lyu WT, Cai MX, Wu HL and Shang J:
Effect of metabolic diseases on emotional and cognitive functions
and its potential mechanisms research progress. Chin J Pharmacol
Toxicol. 29:847–858. 2015.
|
|
21
|
Zhang C, Yuan W, Fang J, Wang W, He P, Lei
J and Wang C: Efficacy of resveratrol supplementation against
non-alcoholic fatty liver disease: A meta-analysis of
placebo-controlled clinical trials. PLoS One.
11(e0161792)2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
de Avelar CR, Pereira EM, de Farias Costa
PR, de Jesus RP and de Oliveira LPM: Effect of silymarin on
biochemical indicators in patients with liver disease: Systematic
review with meta-analysis. World J Gastroenterol. 23:5004–5017.
2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Asbaghi O, Ghanbari N, Shekari M, Reiner
Z, Amirani E, Hallajzadeh J, Mirsafaei L and Asemi Z: The effect of
berberine supplementation on obesity parameters, inflammation and
liver function enzymes: A systematic review and meta-analysis of
randomized controlled trials. Clin Nutr ESPEN. 38:43–49.
2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Faghihzadeh F, Adibi P, Rafiei R and
Hekmatdoost A: Resveratrol supplementation improves inflammatory
biomarkers in patients with nonalcoholic fatty liver disease. Nutr
Res. 34:837–843. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Berman AY, Rachel A, Motechin RA,
Wiesenfeld MY and Holz MK: The therapeutic potential of
resveratrol: A review of clinical trials. NPJ Precis Oncol.
1(35)2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Shrestha PM and Dhillion SS: Medicinal
plant diversity and use in the highlands of Dolakha district,
Nepal. J Ethnopharmacol. 86:81–96. 2003.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Asase A, Kokubun T, Grayer RJ, Kite G,
Simmonds MS, Oteng Yeboah AA and Odamtten GT: Chemical constituents
and antimicrobial activity of medicinal plants from Ghana:
Cassia sieberiana, Haematostaphis barteri,
Mitragyna inermis and Pseudocedrela kotschyi.
Phytother Res. 22:1013–1016. 2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sunitha P, Sathyanarayana N, Suresh VC,
Sreeramanan S, Annie JS and Xavier R: Phytochemical and antioxidant
analysis of the leaf extract of Malaysian medicinal plant Abroma
augusta L. Indian J Pharm Sci. 80:192–198. 2018.
|
|
29
|
Hazra K, Dutta S, Mandal AK, Ravte RK,
Mitra A and Hazra J: Pharmacognostical and phytochemical blueprint
of Abroma augusta L. stem bark. Indian J Nat Prod Resour.
12:271–280. 2021.
|
|
30
|
Islam MS, Ahammed MS, Sukorno FI, Koly SF,
Biswas MM and Hossain S: A review on phytochemical and
pharmacological potentials of Antidesma bunius. J Anal Pharm
Res. 7:602–604. 2018.
|
|
31
|
Xu Y, Liu J, Zeng Y, Jin S, Liu W, Li Z,
Qin X and Bai Y: Traditional uses, phytochemistry, pharmacology,
toxicity and quality control of medicinal genus Aralia: A review. J
Ethnopharmaco. 284(114671)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wang Z, Hu J, Su Z, Li C, Li R, Tang H and
Yi Y: Liver-protective activity of Aralia taibaiensis Z.Z.
Wang et H.C. Zheng. Zhongguo Zhong Yao Za Zhi. 22:307–308.
1997.PubMed/NCBI(In Chinese).
|
|
33
|
Hao Y, Sang Y and Zhao Y: The advancement
of the studies on the seeds of Cassia obtusifolia. Chin
Tradit Herb Drugs. 32:858–859. 2001.
|
|
34
|
Chen Y, Chen X, Yang X, Gao P, Yue C, Wang
L, Wu T, Jiang T, Wu H, Tang L and Wang Z: Cassiae semen: A
comprehensive review of botany, traditional use, phytochemistry,
pharmacology, toxicity, and quality control. J Ethnopharmacol.
306(116199)2023.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Memariani Z, Gorji N, Moeini R and Farzaei
MH: Chapter two: Traditional uses: In Phytonutrients in Food.
Woodhead Publishing, pp23-66, 2020.
|
|
36
|
Paul A and Cox PA: An ethnobotanical
survey of the use for Citrus auranticum (Rutaceae) in Haiti.
Econ Bot. 49:249–256. 1995.
|
|
37
|
Araujo CC and Leon LL: Biological
activities of Curcuma longa L. Mem Inst Oswaldo Cruz.
96:723–728. 2001.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Yildirim MU, Sarihan EO and Khawar KM:
Ethnomedicinal and traditional usage of saffron (Crocus sativus L.)
in Turkey: In Saffron. Academic Press, pp21-31, 2020.
|
|
39
|
Hausenblas HA, Heekin K, Mutchie HL and
Anton S: A systematic review of randomized controlled trials
examining the effectiveness of saffron (Crocus sativus L.)
on psychological and behavioral outcome. J Integr Med. 13:231–240.
2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Webb L: Some new records of medicinal
plants used by the aborigines of tropical Queensland and New
Guinea. Proc R Soc Qld. 71:103–110. 1960.
|
|
41
|
Holdsworth D and Rali T: A survey of
medicinal plants of the Southern Highlands, Papua New Guinea. Int J
Crude Drug Res. 27:1–8. 1989.
|
|
42
|
Li TS: Taiwanese native medicinal plants:
Phytopharmacology and therapeutic values. Routledge and CRC Press.
110(183)2006.
|
|
43
|
Wu MJ, Weng CY, Ding HY and Wu PJ:
Anti-inflammatory and antiviral effects of Glossogyne
tenuifolia. Life Sci. 76:1135–1146. 2005.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Morton JF: Fruits of warm climates. J.F.
Morton, 1987.
|
|
45
|
Hou DX, Tong X, Terahara N, Luo D and Fuji
M: Delphinidin 3-sambubioside, a Hibiscus anthocyanin, induces
apoptosis in human leukemia cells through reactive oxygen
species-mediated mitochondrial pathway. Arch Biochem Biophys.
440:101–109. 2005.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Mapfumo M, Lembede BW, Nkomozepi P,
Ndhlala AR and Chivandi E: Crude Moringa oleifera Lam. seed
extract attenuates non-alcoholic fatty liver disease in growing
Sprague-Dawley rats. S Afr J Bot. 129:191–197. 2020.
|
|
47
|
Biswas SK, Chowdhury A, Das J, Roy A and
Hosen SZ: Pharmacological potentials of Moringa oleifera Lam
A review. Int J Pharm Sci Res. 3:305–310. 2012.
|
|
48
|
Sastri B: The wealth of India, a
dictionary of raw material and industrial products. Publ Inf Dir.
5:285–293. 1950.
|
|
49
|
Hussain F, Rana Z, Shafique H, Malik A and
Hussain Z: Phytopharmacological potential of different species of
Morus alba and their bioactive phytochemicals: A review.
Asian Pac J Trop Biomed. 7:950–956. 2017.
|
|
50
|
Wang T, Guo R, Zhou G, Zhou X, Kou Z, Sui
F, Li C, Tang L and Wang Z: Traditional uses, botany,
phytochemistry, pharmacology and toxicology of Panax
notoginseng (Burk.) F.H. Chen: A review. J Ethnopharmacol.
188:234–258. 2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Tung NH, Uto T, Morinaga O, Kim YH and
Shoyama Y: Pharmacological effects of ginseng on liver functions
and diseases: A minireview. Evid Based Complement Alternat Med.
2012(173297)2012.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Mirunalini S and Krishnaveni M:
Therapeutic potential of Phyllanthus emblica (amla): The
ayurvedic wonder. J Basic Clin Physio Pharmacol. 21:93–105.
2010.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Shetty SN, Mengi S, Vaidya R and Vaidya
ADB: A study of standardized extracts of Picrorhiza kurroa
Royle ex Benth in experimental nonalcoholic fatty liver disease. J
Ayurveda Integr Med. 1:203–210. 2010.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Hajou RMK, Afifi FU and Battah AH:
Comparative determination of multi-pesticide residues in
Pimpinella anisum using two different AOAC methods. Food
Chem. 88:469–478. 2004.
|
|
55
|
Jonas WB: Dictionary of complementary and
alternative medicine. J Altern Complement Med. 11:739–740.
2005.
|
|
56
|
Andarwulan N, Batari R, Sandrasari DA,
Bolling B and Wijaya H: Flavonoid content and antioxidant activity
of vegetables from Indonesia. Food Chem. 121:1231–1235.
2010.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Suriyaphan O: Nutrition, health benefits
and applications of Pluchea indica (L.) less leaves. Mahidol
Univ J Pharm Sci. 41:1–10. 2014.
|
|
58
|
Duke JA: Handbook of medicinal herbs. 2nd
edition. CRC press, 2002.
|
|
59
|
Heinrich M, Kufer J, Leonti M and
Pardo-de-Santayana M: Ethnobotany and
ethnopharmacology-interdisciplinary links with the historical
sciences. J Ethnopharmacol. 107:157–160. 2006.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Ody P: The complete medicinal herbal.
Dorling Kindersley, 1993.
|
|
61
|
Tao Y, Bao J, Zhu F, Pan M, Liu Q and Wang
P: Ethnopharmacology of Rubus idaeus Linnaeus: A critical
review on ethnobotany, processing methods, phytochemicals,
pharmacology and quality control. J Ethnopharmacol.
302(115870)2023.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Sun W, Shahrajabian MH and Cheng Q:
Fenugreek cultivation with emphasis on historical aspects and its
uses in traditional medicine and modern pharmaceutical science.
Mini Rev Med Chem. 21:724–730. 2021.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Kohli R and Feldstein AE: NASH animal
models: Are we there yet? J Hepatol. 55:941–943. 2011.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Takahashi Y, Soejima Y and Fukusato T:
Animal models of nonalcoholic fatty liver disease/nonalcoholic
steatohepatitis. World J Gastroenterol. 18:2300–2308.
2012.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Ganz M and Szabo G: Immune and
inflammatory pathways in NASH. Hepatol Int. 7 (Suppl 2):S771–S781.
2013.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Brunt EM and Tiniakos DG: Histopathology
of non-alcoholic fatty liver disease. World J Gastroenterol.
16:5286–5296. 2010.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Kirsch R, Clarkson V, Shephard EG, Marais
DA, Jaffer MA, Woodburne VE, Kirsch RE and Hall Pde L: Rodent
nutritional model of non-alcoholic steatohepatitis: species, strain
and sex difference studies. J Gastroenterol Hepatol. 18:1272–1282.
2003.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Le Roy T, Llopis M, Lepage P, Bruneau A,
Rabot S, Bevilacqua C, Martin P, Philippe C, Walker F, Bado A, et
al: Intestinal microbiota determines development of non-alcoholic
fatty liver disease in mice. Gut. 62:1787–1794. 2013.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Harrison SA, Loomba R, Dubourg J, Ratziu V
and Noureddin M: Clinical trial landscape in NASH. Clin
Gastroenterol Hepatol. 21:2001–2014. 2023.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Ito M, Suzuki J, Tsujioka S, Sasaki M,
Gomori A, Shirakura T, Hirose H, Ito M, Ishihara A, Iwaasa H and
Kanatani A: Longitudinal analysis of murine steatohepatitis model
induced by chronic exposure to high-fat diet. Hepatol Res.
37:50–57. 2007.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Ibrahim SH, Hirsova P, Malhi H and Gores
GJ: Animal models of nonalcoholic steatohepatitis: Eat, delete, and
inflame. Dig Dis Sci. 61:1325–1336. 2016.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Rinella ME and Green RM: The
methionine-choline deficient dietary model of steatohepatitis does
not exhibit insulin resistance. J Hepatol. 40:47–51.
2004.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Van Herck MA, Vonghia L and Francque SM:
Animal models of nonalcoholic fatty liver disease-A starter's
guide. Nutrients. 9(1072)2017.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Matsumoto M, Hada N, Sakamaki Y, Uno A,
Shiga T, Tanaka C, Ito T, Katsume A and Sudoh M: An improved mouse
model that rapidly develops fibrosis in non-alcoholic
steatohepatitis. Int J Exp Pathol. 94:93–103. 2013.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Clapper JR, Hendricks MD, Gu G, Wittmer C,
Dolman CS, Herich J, Athanacio J, Villescaz C, Ghosh SS, Heilig JS,
et al: Diet-induced mouse model of fatty liver disease and
nonalcoholic steatohepatitis reflecting clinical disease
progression and methods of assessment. Am J Physiol Gastrointest
Liver Physiol. 305:G483–G495. 2013.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Kubota N, Kado S, Kano M, Masuoka N,
Nagata Y, Kobayashi T, Miyazaki K and Ishikawa F: A high-fat diet
and multiple administration of carbon tetrachloride induces liver
injury and pathological features associated with non-alcoholic
steatohepatitis in mice. Clin Exp Pharmacol Physiol. 40:422–430.
2013.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Mamikutty N, Thent ZC and Haji Suhaimi F:
Fructose-drinking water induced nonalcoholic fatty liver disease
and ultrastructural alteration of hepatocyte mitochondria in male
wistar rat. Biomed Res Int. 2015(895961)2015.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Bergheim I, Weber S, Vos M, Krämer S,
Volynets V, Kaserouni S, McClain CJ and Bischoff SC: Antibiotics
protect against fructose-induced hepatic lipid accumulation in
mice: Role of endotoxin. J Hepatol. 48:983–992. 2008.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Arroyave-Ospina JC, Wu Z, Geng Y and
Moshage H: Role of oxidative stress in the pathogenesis of
non-alcoholic fatty liver disease: Implications for prevention and
therapy. Antioxidants (Basel). 10(174)2021.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Asokan SM, Wang RY, Hung TH and Lin WT:
Hepato-protective effects of Glossogyne tenuifolia in
Streptozotocin-nicotinamide-induced diabetic rats on high fat diet.
BMC Complement Altern Med. 19(117)2019.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Yadav AK and Singh A: Hepatoprotective and
antioxidant activity of ethanolic leaves extract of abroma augusta
against non-alcoholic fatty liver disease (Nafld) in SD rats. Int J
Pharm Sci Res. 12:316–326. 2022.
|
|
82
|
Ngamlerst C, Udomkasemsab A,
Kongkachuichai R, Kwanbunjan K, Chupeerach C and Prangthip P: The
potential of antioxidant-rich Maoberry (Antidesma bunius)
extract on fat metabolism in liver tissues of rats fed a high-fat
diet. BMC Complement Altern Med. 19(294)2019.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Chowtivannakul P, Srichaikul B and
Talubmook C: Hypoglycemic and hypolipidemic effects of seed extract
from Antidesma bunius (L.) spreng in streptozotocin-induced
diabetic rats. Pak J Biol Sci. 19:211–218. 2016.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Hwang KA, Hwang YJ, Kim GR and Choe JS:
Extracts from Aralia elata (Miq) Seem alleviate
hepatosteatosis via improving hepatic insulin sensitivity. BMC
Complement Altern Med. 15(347)2015.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Yang HK, Jin JY, Kim JM, Ko MS, Hong HJ,
Kim SC and Lee YJ: Single Oral Dose Toxicity Study of the Extract
of Aralia elata in Mice. J Toxical Pub Health. 22:439–443.
2006.
|
|
86
|
Qi M, Hua X, Peng X, Yan X and Lin J:
Comparison of chemical composition in the buds of Aralia
elata from different geographical origins of China. R Soc Open
Sci. 5(180676)2018.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Meng Y, Liu Y, Fang N and Guo Y:
Hepatoprotective effects of Cassia semen ethanol extract on
non-alcoholic fatty liver disease in experimental rat. Pharm Biol.
57:98–104. 2019.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Dong X, Fu J, Yin X, Yang C, Zhang X, Wang
W, Du X, Wang Q and Ni J: Cassiae semen: A review of its
phytochemistry and pharmacology (Review). Mol Med Rep.
16:2331–2346. 2017.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Zhang HF, Bai JP, Yu JZ, Yang LZ, Feng L
and Ma CG: Long-term toxicity test of semen cassiae hawthorn oat
capsules. Chin J Nat Med. 12:412–414. 2010.
|
|
90
|
Han HY, Lee SK, Choi BK, Lee DR, Lee HJ
and Kim TW: Preventive effect of Citrus aurantium peel
extract on high-fat diet-induced non-alcoholic fatty liver in mice.
Biol Pharm Bull. 42:255–260. 2019.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Suntar I, Khan H, Patel S, Celano R and
Rastrelli L: An overview on Citrus aurantium L.: Its
functions as food ingredient and therapeutic agent. Oxid Med Cell
Longev. 2018(7864269)2018.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Arbo MD, Schmitt GC, Limberger MF, Charão
MF, Moro AM, Ribeiro GL, Dallegrave E, Garcia SC, Leal MB and
Limberger RP: Subchronic toxicity of Citrus aurantium L.
(Rutaceae) extract and p-synephrine in mice. Regul Toxicol
Pharmacol. 54:114–117. 2009.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Deshmukh NS, Stohs SJ, Magar CC and Kadam
SB: Citrus aurantium (bitter orange) extract: Safety
assessment by acute and 14-day oral toxicity studies in rats and
the Ames Test for mutagenicity. Regul Toxicol Pharmacol.
90:318–327. 2017.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Mun J, Kim S, Yoon HG, You Y, Kim OK, Choi
KC, Lee YH, Lee J, Park J and Jun W: Water extract of Curcuma
longa L. Ameliorates non-alcoholic fatty liver disease.
Nutrients. 11(2536)2019.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Ahmad RS, Hussain MB, Sultan MT, Arshad
MS, Waheed M, Shariati MA, Plygun S and Hashempur MH: Biochemistry,
Safety, pharmacological activities, and clinical applications of
turmeric: A mechanistic review. Evid Based Complementary Altern
Med. 2020(7656919)2020.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Murugan S, Solanki H, Purusothaman D,
Bethapudi B, Ravalji M and Mundkinajeddu D: Safety evaluation of
standardized extract of Curcuma longa (NR-INF-02): A 90-day
subchronic oral toxicity study in rats. Biomed Res Int.
2021(6671853)2021.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Sabir U, Irfan HM, Alamgeer A, Ullah YS,
Althobaiti MH and Asim MF: Reduction of hepatic steatosis,
oxidative stress, inflammation, ballooning and insulin resistance
after therapy with safranal in NAFLD animal model: A new approach.
J Inflamm Res. 15:1293–1316. 2022.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Hosseinzadeh H, Sadeghi Shakib S, Khadem
Sameni A and Taghiabadi E: Acute and subacute toxicity of safranal
a constituent of saffron in mice and rats. Iran J Pharm Res.
12:93–99. 2013.PubMed/NCBI
|
|
99
|
El Daly ES: Protective effect of cysteine
and vitamin E, Crocus sativus and Nigella sativa
extracts on cisplatin-induced toxicity in rats. J Islamic Acad Sci.
9:105–118. 1996.PubMed/NCBI
|
|
100
|
Songtrai S, Dejyong K and Kaewsuwan S:
Acute oral toxicological evaluation in Wistar rats of
interruptin-rich extract from Cyclosorus terminans and its
in vitro antidiabetic potential. J Pharm Pharmacogn Res.
10:800–811. 2022.
|
|
101
|
Songtrai S, Pratchayasakul W, Arunsak B,
Chunchai T, Kongkaew A, Chattipakorn N, Chattipakorn SC and
Kaewsuwan S: Cyclosorus terminans extract ameliorates
insulin resistance and non-alcoholic fatty liver disease (NAFLD) in
high-fat diet (HFD)-induced obese rats. Nutrients.
14(4895)2022.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Quadri Spinelli T, Heilmann J, Rali T and
Sticher O: Bioactive coumarin derivatives from the fern
Cyclosorus interruptus. Planta Med. 66:728–733.
2000.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Tien YH, Chen BH, Wang Hsu GS, Lin WT,
Huang JH and Lu YF: Hepatoprotective and anti-oxidant activities of
Glossogyne tenuifolia against acetaminophen-induced
hepatotoxicity in mice. Am J Chin Med. 42:1385–1398.
2014.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Njinga NS, Kola-Mustapha AT, Quadri AL,
Atolani O, Ayanniyi RO, Buhari MO, Amusa TO, Ajani EO, Folaranmi
OO, Bakare-Odunola MT, et al: Toxicity assessment of sub-acute and
sub-chronic oral administration and diuretic potential of aqueous
extract of Hibiscus sabdariffa calyces. Heliyon.
6(e04853)2020.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Prasomthong J, Limpeanchob N, Daodee S,
Chonpathompikunlert P and Tunsophon S: Hibiscus sabdariffa
extract improves hepatic steatosis, partially through IRS-1/Akt and
Nrf2 signaling pathways in rats fed a high fat diet. Sci Rep.
12(7022)2022.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Kim Y, Jaja-Chimedza A, Merrill D, Mendes
O and Raskin I: A 14-day repeated-dose oral toxicological
evaluation of an isothiocyanate-enriched hydro-alcoholic extract
from Moringa oleifera Lam. seeds in rats. Toxicol Rep.
5:418–426. 2018.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Mary SV and Jibu T: The effect of M.
latifolia leaf extract on high-fructose corn syrup
(HFCS)-induced non-alcoholic fatty liver disease in rat models in
nonalcoholic fatty liver disease. IntechOpen Rijeka P Ch 2,
2019.
|
|
108
|
Li Y, Zhang X, Liang C, Hu J and Yu Z:
Safety evaluation of mulberry leaf extract: Acute, subacute
toxicity and genotoxicity studies. Regul Toxicol Pharmacol.
95:220–226. 2018.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Hou Y, Gu D, Peng J, Jiang K, Li Z, Shi J,
Yang S, Li S and Fan X: Ginsenoside Rg1 regulates liver lipid
factor metabolism in NAFLD model rats. ACS Omega. 5:10878–10890.
2020.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Luo X, Zhang B, Pan Y, Gu J, Tan R and
Gong P: Phyllanthus emblica aqueous extract retards hepatic
steatosis and fibrosis in NAFLD mice in association with the
reshaping of intestinal microecology. Front Pharmacol.
13(893561)2022.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Anto EJ, Syahputra RA, Silitonga HA,
Situmorang PC and Nugaraha SE: Oral acute toxicity study extract
ethanol of balakka fruit (Phyllanthus emblica). Pharmacia.
69:187–194. 2022.
|
|
112
|
Krishna AB, Manikyam HK, Sharma VK and
Sharma N: Single dose oral toxicity study of Picrorhiza
kurroa rhizome extract in Wistar rats. Fundam Toxicol Sci.
3:9–12. 2016.
|
|
113
|
Asadollahpoor A, Abdollahi M and Rahimi R:
Pimpinella anisum L. fruit: Chemical composition and effect
on rat model of nonalcoholic fatty liver disease. J Res Med Sci.
22(37)2017.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Singdam P, Naowaboot J, Senggunprai L,
Boonloh K and Pannangpetch P: Pluchea indica leaf extract
alleviates dyslipidemia and hepatic steatosis by modifying the
expression of lipid metabolism-related genes in rats fed a high
fat-high fructose diet. Prev Nutr Food Sci. 27:384–398.
2022.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Wang SJ, Chen Q, Liu MY, Yu HY, Xu JQ, Wu
JQ and Wang T: Regulation effects of rosemary (Rosmarinus
officinalis Linn.) on hepatic lipid metabolism in OA induced
NAFLD rats. Food Funct. 10:7356–7365. 2019.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Anadón A, Martínez-Larrañaga MR, Martínez
MA, Ares I, García-Risco MR, Señoráns FJ and Reglero G: Acute oral
safety study of rosemary extracts in rats. J Food Prod. 71:790–795.
2008.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Ma Y, Xiu W, Wang X and Yang Q: Extraction
of raspberry ketone from red raspberry and its intervention in the
non-alcoholic fatty liver disease. Appl Biol Chem. 65(78)2022.
|
|
118
|
Frías-Moreno MN, Parra-Quezada RA,
González-Aguilar G, Ruíz-Canizales J, Molina-Corral FJ, Sepulveda
DR, Salas-Salazar N and Olivas GI: Quality, bioactive compounds,
antioxidant capacity, and enzymes of raspberries at different
maturity stages, effects of organic vs. conventional fertilization.
Foods. 10(953)2021.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Kumar P, Bhandari U and Jamadagni S:
Fenugreek seed extract inhibit fat accumulation and ameliorates
dyslipidemia in high fat diet-induced obese rats. Biomed Res Int.
2014(606021)2014.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Al-Ashban R, Abou-Shaaban R and Shah A:
Toxicity studies on Trigonella foenum-graecum L. seeds used
in spices and as a traditional remedy for diabetes. Adv Trad Med.
10:66–78. 2010.
|
|
121
|
Muralidhara Narasimhamurthy K, Viswanatha
S and Ramesh BS: Acute and subchronic toxicity assessment of
debitterized fenugreek powder in the mouse and rat. Food Chem
Toxicol. 37:831–838. 1999.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Jeon SH, Jang E, Park G, Lee Y, Jang YP,
Lee KT, Inn KS, Lee JK and Lee JH: Beneficial activities of
Alisma orientale extract in a western diet-induced murine
non-alcoholic steatohepatitis and related fibrosis model via
Regulation of the hepatic adiponectin and farnesoid X receptor
pathways. Nutrients. 14(695)2022.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Utzschneider KM and Kahn SE: Review: The
role of insulin resistance in nonalcoholic fatty liver disease. J
Clin Endocrinol Metab. 91:4753–4761. 2006.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Loomba R, Abraham M, Unalp A, Wilson L,
Lavine J, Doo E and Bass NM: Nonalcoholic Steatohepatitis Clinical
Research Network. Association between diabetes, family history of
diabetes, and risk of nonalcoholic steatohepatitis and fibrosis.
Hepatology. 56:943–951. 2012.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Haas ME, Attie AD and Biddinger SB: The
regulation of ApoB metabolism by insulin. Trends Endocrinol Metab.
24:391–397. 2013.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Park PH, Sanz-Garcia C and Nagy LE:
Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in
the liver. Curr Pathobiol Rep. 3:243–252. 2015.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Marra F and Lotersztajn S: Pathophysiology
of NASH: Perspectives for a targeted treatment. Curr Pharm Des.
19:5250–5269. 2013.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Jamal N, Zainol NI, Zakaria NA, Jofrry SM,
Mohamed R, Man F and Choo CY: Safety, efficacy, and mechanism of
action of herbs used for obesity management: A thematic review.
Obes Med. 32(100415)2022.
|
